Medium-term outcome following intra-articular corticosteroid injection in first CMC joint arthritis using fluoroscopy.
First carpometacarpal joint osteoarthritis (1(st) CMCJ OA) is a common condition with variable results reported from local corticosteroid injection. This study aims to explore the medium-term outcome with respect to pain relief, patient satisfaction and the need for subsequent surgical intervention. A prospective review was performed of patients undergoing fluoroscopically guided corticosteroid injection by one surgeon, with postal questionnaires for medium-term follow-up. Forty-one patients were included. Thirty-one were female and ten male, with a mean age of 60 years. In the short term 76% of patients reported pain relief with an average duration of four weeks and 69% of the patients reported benefit from injection. After a median follow-up of 36 months 76% of patients reported continuing pain but 59% reported satisfaction with the outcome. Twenty-eight per cent of the patients had undergone surgery. Local corticosteroid injection of the CMCJ provides only short-term pain relief, but few patients go on to surgical intervention.
Maarse
Wies
W
Department of Plastic, Reconstructive and Hand Surgery, University of Utrecht, The Netherlands.
Watts
Adam C
AC
Bain
Gregory I
GI
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001623:Betamethasone / Q000627:therapeutic use*; D052737:Carpometacarpal Joints / Q000503:physiopathology*; D005260:Female; D005471:Fluoroscopy; D005500:Follow-Up Studies; D006801:Humans; D007270:Injections, Intra-Articular; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy* / Q000503:physiopathology; D010147:Pain Measurement; D017060:Patient Satisfaction; D015641:Radiography, Interventional; D019233:Retreatment; D012189:Retrospective Studies; D011795:Surveys and Questionnaires
D000305:Adrenal Cortex Hormones; D001623:Betamethasone